CNXC vs PATH · rev $9.62B vs P/E 19, rev $1.61B
Concentrix Corporation (CNXC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Concentrix Corporation (CNXC) is a information technology services company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CNXC revenue for 2024-11-30 was $9.62B. Net income was $251.2M. Revenue was up 35.2% from 2023-11-30 to 2024-11-30. CNXC currently screens at market cap $1.70B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CNXC currently screens at market cap $1.70B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CNXC and PATH stock pages for the full models.
Not investment advice.